AKT1 and colonic neoplasm: Studies have found that tetrandrine can upregulate the mRNA and protein levels of BMP9 in colon cancer cells, and finally inhibit the proliferation of colon cancer cells through BMP9/PTEN/PI3K/AKT signaling [13].